Comparison of the Infarct Size between the Loading of Ticagrelor and Clopidogrel in Patients with Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

BACKGROUND AND OBJECTIVES: Ticagrelor is considered a potent antiplatelet agent compared to clopidogrel. However, there are no studies regarding the effect of ticagrelor loading on infarct size in patients with ST-segment elevation myocardial infarction (STEMI) in a primary percutaneous coronary int...

Descripción completa

Detalles Bibliográficos
Autores principales: Yun, Kyeong Ho, Rhee, Sang Jae, Ko, Jum Suk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Cardiology 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5614947/
https://www.ncbi.nlm.nih.gov/pubmed/28955389
http://dx.doi.org/10.4070/kcj.2017.0044

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5614947/
https://www.ncbi.nlm.nih.gov/pubmed/28955389
http://dx.doi.org/10.4070/kcj.2017.0044

Ejemplares similares